Relmada Therapeutics Inc.

0.26
-0.02 (-5.76%)
At close: Apr 04, 2025, 10:19 AM

Relmada Therapeutics Statistics

Share Statistics

Relmada Therapeutics has 33.19M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding 33.19M
Shares Change (YoY) 0%
Shares Change (QoQ) 0%
Owned by Institutions (%) 27.74%
Shares Floating 27.81M
Failed to Deliver (FTD) Shares 12.32K
FTD / Avg. Volume 1.26%

Short Selling Information

The latest short interest is 1.26M, so 4.16% of the outstanding shares have been sold short.

Short Interest 1.26M
Short % of Shares Out 4.16%
Short % of Float 4.97%
Short Ratio (days to cover) 4.52

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -0.27. Relmada Therapeutics's PEG ratio is 0.

PE Ratio 0
Forward PE -0.27
PS Ratio 0
Forward PS null
PB Ratio 0.44
P/FCF Ratio -0.3
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Relmada Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.

Current Ratio 4.45
Quick Ratio 4.45
Debt / Equity 0
Debt / EBITDA -
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $0
Employee Count 17
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -75.21% in the last 52 weeks. The beta is 0.41, so Relmada Therapeutics's price volatility has been higher than the market average.

Beta 0.41
52-Week Price Change -75.21%
50-Day Moving Average 0.31
200-Day Moving Average 0.62
Relative Strength Index (RSI) 43.84
Average Volume (20 Days) 976.97K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income 0
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) 0
Full Income Statement

Balance Sheet

The company has 3.86M in cash and 0 in debt, giving a net cash position of 3.86M.

Cash & Cash Equivalents 3.86M
Total Debt 0
Net Cash 3.86M
Retained Earnings -640.88M
Total Assets 45.82M
Working Capital 35.5M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -51.76M and capital expenditures 0, giving a free cash flow of -51.76M.

Operating Cash Flow -51.76M
Capital Expenditures 0
Free Cash Flow -51.76M
FCF Per Share -1.72
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for RLMD is $1, which is 244.8% higher than the current price. The consensus rating is "Hold".

Price Target $1
Price Target Difference 244.8%
Analyst Consensus Hold
Analyst Count 4
Stock Forecasts

Stock Splits

The last stock split was on Sep 30, 2019. It was a backward split with a ratio of 1:4.

Last Split Date Sep 30, 2019
Split Type backward
Split Ratio 1:4

Scores

Altman Z-Score -25.56
Piotroski F-Score 2